8-K
0001627223false00016272232023-04-262023-04-26

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

April 26, 2023

Date of Report (Date of Earliest Event Reported)

https://cdn.kscope.io/d3a2ff4d904c9b85ff549916f2394627-img171760532_0.jpg 

The Chemours Company

(Exact Name of Registrant as Specified in Its Charter)

 

Delaware

 

001-36794

 

46-4845564

(State or Other Jurisdiction

 

(Commission

 

(I.R.S. Employer

Of Incorporation)

 

File Number)

 

Identification No.)

 

1007 Market Street

Wilmington, Delaware 19801

(Address of principal executive offices)

 

Registrant’s telephone number, including area code: (302) 773-1000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class

 

Trading Symbol(s)

 

Name of Exchange on Which Registered

Common Stock ($0.01 par value)

 

CC

 

New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

Emerging growth company

 

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

 


Item 5.07 Submission of Matters to a Vote of Security Holders.

The Chemours Company (the “Company”) held its annual meeting of shareholders on April 26, 2023 (the “Annual Meeting”).

At the Annual Meeting, shareholders:

elected all nine director nominees to serve a one-year term;
approved the Company’s annual “say-on-pay” vote on an advisory basis;
ratified PricewaterhouseCoopers LLP as the Company’s independent registered public accounting firm.

The final voting results for each proposal were as follows:

Proposal 1 – Election of Directors to Serve One-Year Term

 

Nominee

For

Against

Abstain

Total

Broker Non-Votes

Curtis V. Anastasio

107,854,520 (97.12%)

2,733,970

469,009

111,057,499

18,363,002

Mary B. Cranston

108,395,830

(97.60%)

2,205,276

456,396

111,057,502

18,362,999

Curtis J. Crawford

109,633,207 (98.72%)

1,101,759

322,536

111,057,502

18,362,999

Dawn L. Farrell

109,835,964 (98.90%)

886,086

335,451

111,057,501

18,363,000

Erin N. Kane

109,501,453 (98.60%)

1,345,577

210,472

111,057,502

18,362,999

Sean D. Keohane

108,652,406 (97.83%)

1,937,892

467,202

111,057,500

18,363,001

Mark E. Newman

110,182,323 (99.21%)

550,858

324,320

111,057,501

18,363,000

Guillaume Pepy

108,385,679 (97.59%)

2,336,154

335,668

111,057,501

18,363,000

Sandra P. Rogers

108,911,475 (98.07%)

1,646,276

499,745

111,057,496

18,363,005

Proposal 2 – Advisory Vote to Approve Named Executive Officer Compensation

 

For

Against

Abstain

Total

Broker Non-Votes

106,793,855

(96.16%)

3,723,910

539,725

111,057,490

18,363,011

Proposal 3 – Ratification of Selection of Independent Registered Public Accounting Firm

 

For

Against

Abstain

Total

Broker Non-Votes

128,403,641 (99.21%)

785,881

230,979

129,420,501

n/a

 


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

THE CHEMOURS COMPANY

 

By:

 

/s/ Sameer Ralhan

 

 

Sameer Ralhan

 

 

Senior Vice President, Chief Financial Officer

Date:

 

April 27, 2023